0001790300-21-000008.txt : 20210917
0001790300-21-000008.hdr.sgml : 20210917
20210917182554
ACCESSION NUMBER: 0001790300-21-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210722
FILED AS OF DATE: 20210917
DATE AS OF CHANGE: 20210917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BLACKFORD GARY
CENTRAL INDEX KEY: 0001156320
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37897
FILM NUMBER: 211261626
MAIL ADDRESS:
STREET 1: 7700 FRANCE AVENUE SOUTH
CITY: EDINA
STATE: MN
ZIP: 55435
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ReShape Lifesciences Inc.
CENTRAL INDEX KEY: 0001427570
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
BUSINESS PHONE: 949-429-6680
MAIL ADDRESS:
STREET 1: 1001 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
FORMER COMPANY:
FORMER CONFORMED NAME: OBALON THERAPEUTICS INC
DATE OF NAME CHANGE: 20080220
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-07-22
0
0001427570
ReShape Lifesciences Inc.
RSLS
0001156320
BLACKFORD GARY
1001 CALLE AMANECER
SAN CLEMENTE
CA
92673
1
0
0
0
Common Stock, $0.001 par value per share
2021-07-22
4
A
0
253429
0
A
253429
D
These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
/s/Gary D. Blackford
2021-09-17